Ind-Swift Laboratories Limited — Important, 04-08-2025: General Updates

Essix Biosciences Limited has significantly increased its stake in IND-SWIFT LABORATORIES. The entity acquired 1.1 million new equity shares through the conversion of warrants. This development solidifies Essix Biosciences' position as a key shareholder, reflecting a strategic move and long-term commitment. For retail investors, this means a substantial block of shares is now held by a single entity, potentially influencing future corporate governance and strategic decisions. This move highlights a strengthened alignment between the two entities.